TH168567B - Insulin composition, rapid-acting - Google Patents
Insulin composition, rapid-actingInfo
- Publication number
- TH168567B TH168567B TH1601006639A TH1601006639A TH168567B TH 168567 B TH168567 B TH 168567B TH 1601006639 A TH1601006639 A TH 1601006639A TH 1601006639 A TH1601006639 A TH 1601006639A TH 168567 B TH168567 B TH 168567B
- Authority
- TH
- Thailand
- Prior art keywords
- insulin
- acting
- rapid
- humen
- insulin composition
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract 17
- 108090001061 Insulin Proteins 0.000 title claims abstract 7
- 102000004877 Insulin Human genes 0.000 title claims abstract 7
- 239000000203 mixture Substances 0.000 title claims abstract 5
- RCHHVVGSTHAVPF-ZPHPLDECSA-N Apidra Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3N=CNC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CNC=N1 RCHHVVGSTHAVPF-ZPHPLDECSA-N 0.000 claims 1
- WNRQPCUGRUFHED-DETKDSODSA-N Humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 claims 1
- 108010073961 Insulin Aspart Proteins 0.000 claims 1
- 108010065920 Insulin Lispro Proteins 0.000 claims 1
- 229960002068 Insulin Lispro Drugs 0.000 claims 1
- VOMXSOIBEJBQNF-UTTRGDHVSA-N NovoRapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229960004717 insulin aspart Drugs 0.000 claims 1
- 229960000696 insulin glulisine Drugs 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 claims 1
- 241001644482 Onyx Species 0.000 abstract 1
- 230000036231 pharmacokinetics Effects 0.000 abstract 1
Abstract
แก้ไข 20/01/2560 การประดิษฐ์คือองค์ประกอบของฮิวเมนอินซูลินหรืออินซูลินอะนาล็อกที่รวมถึงเทรโพรสทิ นิลและที่มีการทำงานทางเภสัชจลนศาสตร์เร็วกว่าสูตรผสมในเชิงพาณิชย์ของผลิตภัณฑ์อินซูลิน อะนาล็อกที่มีอยู่ ------------------------------------------ การประดิษฐ์คือองค์ประกอบของฮิวเมนอินซูลินหรืออินซูลินอะนาล็อกที่รวมถึง เทรโพรสทินิลและที่มีการทำงานทางเกสัชจลนศาสตร์เร็วกว่าสูตรผสมในเชิงพาณิชย์ของผลิตภัณฑ์ อินซูลินอะนาล็อกที่มีอยู่ Revised 20/01/2017 The invention is the composition of humen insulin or insulin analogs that include troprosti. Onyx and with its pharmacokinetics are faster than commercial formulations of insulin products. Analogs available ------------------------------------------ Invention is an element of Humen. Insulin or insulin analogues that include Troprostatinil and it is mechanically active faster than commercial formulations of the product. Available insulin analogues
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH168567A TH168567A (en) | 2017-09-28 |
| TH168567B true TH168567B (en) | 2017-09-28 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201890343A1 (en) | QUICKLY INSULATED COMPOSITIONS | |
| PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
| WO2015106269A8 (en) | Rapid action insulin formulations and pharmaceutical delivery systems | |
| MX2016008978A (en) | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives. | |
| CL2018003319A1 (en) | Mic-1 compounds and uses of these. | |
| EA201990831A1 (en) | MIXING SYSTEM FOR COSMETIC PRODUCT AND COSMETIC CAPSULE | |
| CL2018003178A1 (en) | Pharmaceutical composition | |
| SV2017005515A (en) | NASAL DUST FORMULATIONS FOR THE TREATMENT OF HYPOGLYCEMIA | |
| CL2018003383A1 (en) | Proteins f of stabilization of stabilized vrs. | |
| CL2017001483A1 (en) | Fixed ratio formulation of insulin glargine / lixisenatide | |
| BR112017007393A2 (en) | anti-il-7r antibody compositions | |
| WO2011146922A3 (en) | Materials and methods for treatment of inflammation | |
| WO2017037075A8 (en) | Composition containing echinacea extract and linoleic acid derivatives | |
| EA201700019A1 (en) | HIGHLY PURE ORIENTATION AND METHOD FOR ITS OBTAINING | |
| WO2017093810A3 (en) | Composition for intraoral delivery of biologically active peptides and proteins | |
| EA201891337A2 (en) | PHARMACEUTICAL COMPOSITION FROM NEUROPATHIC PAIN | |
| CL2016003063A1 (en) | Composition based on a stabilized solution of active ingredients | |
| BR112017013269A2 (en) | ? liquid pharmaceutical composition? | |
| TH168567B (en) | Insulin composition, rapid-acting | |
| EA201690395A1 (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING BISOPROLOL AND RAMIPRIL | |
| TH168567A (en) | Insulin composition, rapid-acting | |
| EA201890789A1 (en) | CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES | |
| TR201714964A2 (en) | Effervescent tablet formulations. | |
| TH1901007485A (en) | Rapid-acting insulin composition | |
| UA115290U (en) | COMPOSITION IN THE FORM OF SPRAY FOR ORAL APPLICATION CONTAINING CHOLINE ALPHOSCERATE |